BRISC
LIVE

Serial Number

50141198

Owner

Brii Biosciences Limited

Attorney

Brent D. Sokol

Filing Date

Oct 1, 2026

Add to watchlist:

No watchlists yet
View on USPTO

BRISC Trademark

Serial Number: 50141198

BRISC is a trademark filed by Brii Biosciences Limited on October 1, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Brii Biosciences Limited

WeWork, Suite 05-110
Durham, NC 27701 , KY

Entity Type: 99

Trademark Details

Filing Date

October 1, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of infectious diseases, cancer, metabolic diseases, renal diseases, gout and anemia, cardiovascular disorders, age related diseases, autoimmune system disorders, diabetes, central nervous system disorders, heart and blood disorders, pain, inflammation, sepsis, alopecia, skin, obesity and cognitive disorders; Biopharmaceutical preparations for the treatment of infectious diseases, cancer, metabolic diseases, renal diseases, gout and anemia, cardiovascular disorders, age related diseases, autoimmune system disorders, diabetes, central nervous system disorders, heart and blood disorders, pain, inflammation, sepsis, alopecia, skin, obesity and cognitive disorders

Custom biomanufacturing of pharmaceuticals

Pharmaceutical advice; Providing medical information in the field of siRNA therapy

Research and development in the field of pharmaceuticals; Research and development in the field of life sciences; Research and development in the field of genetics; Research and development in the field of biotechnology; Pharmaceutical research services; Consulting services in the field of pharmaceutical research and development; Laboratory services for biomanufacturing viral vectors for pharmaceutical use; Pharmaceutical research and development; Providing scientific research information in the field of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Development of pharmaceutical preparations and medicines; Research and development of siRNA drugs

Filing History

APPLICATION FILING RECEIPT MAILED
Oct 1, 2026 MAFR
NEW APPLICATION ENTERED
Oct 1, 2026 NWAP